中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 10
Oct.  2021
Turn off MathJax
Article Contents

Influencing factors for the 90-day prognosis of patients with HBV-related acute-on-chronic liver failure

DOI: 10.3969/j.issn.1001-5256.2021.10.011
Research funding:

Health Science and Technology Project of Fuzhou City (2019-S-wq18);

Medical Innovation Project of Fujian Province (2020CXB038);

The National Key Special Program for The Control and Treatment of Major Infectious Diseases of AIDS and Viral Hepatitis (2017ZX10203201);

Infectious Disease Medical Center Construction Program of Fuzhou City (2018080306);

The Key Clinical Specialty Discipline Construction Program of Fujian Province (Min-wei medical political letter 2018, 145)

  • Received Date: 2021-04-26
  • Accepted Date: 2021-06-08
  • Published Date: 2021-10-20
  •   Objective  To investigate the risk factors for short-term prognosis in patients with HBV-related acute-on-chronic liver failure (ACLF).  Methods  A retrospective analysis was performed for the clinical data of 119 patients with HBV-related ACLF who were admitted to Mengchao Hepatobiliary Hospital of Fujian Medical University from October 2019 to October 2020, and according to their survival status on day 90, they were divided into death group and survival group. The patients were given antiviral therapy with entecavir or tenofovir. Related clinical data were collected, including alanine aminotransferase (ALT), aspartate aminotransferase, cholinesterase (ChE), albumin (Alb), cholesterol, alpha-fetoprotein, and HBV DNA at baseline, as well as the incidence rate of important complications. Model for End-Stage Liver Disease (MELD) score was also calculated. The t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the chi-squared test was used for comparison of categorical data between two groups; a logistic regression analysis was used to investigate the influencing factors for the 90-day prognosis of patients with HBV-related ACLF and establish a new predictive model; the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic efficiency of the new model in predicting the prognosis of HBV-related ACLF.  Results  Of all patients, 33 died within 90 days, resulting in a mortality rate of 27.7%. There were significant differences between the survival group and the death group in age, ALT, Alb, ChE, MELD score, and incidence rates of hepatic encephalopathy, primary peritonitis, and hepatorenal syndrome (all P < 0.05). The logistic regression analysis showed that baseline hepatic encephalopathy (odds ratio [OR]=10.404, 95% confidence interval [CI]: 2.522-42.926, P=0.001), serum Alb at baseline (OR=0.853, 95%CI: 0.764-0.952, P=0.005), and MELD score at baseline (OR=1.143, 95%CI: 1.036-1.261, P=0.008) were independent predictive factors for the short-term prognosis of patients with HBV-related ACLF. A new predictive model was established based on the combination of these three indices, and the ROC curve analysis showed that this new model had an area under the curve of 0.833, while MELD score had an area under the ROC curve of 0.672.  Conclusion  As for the evaluation of the 90-day prognosis of patients with HBV-related ACLF, the new prognostic model established based on hepatic encephalopathy, Alb, and MELD score has a better predictive value than MELD score alone.

     

  • loading
  • [1]
    Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.

    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
    [2]
    ZHANG S, WANG F, ZHANG Z. Current advances in the elimination of hepatitis B in China by 2030[J]. Front Med, 2017, 11(4): 490-501. DOI: 10.1007/s11684-017-0598-4.
    [3]
    REN Y, LIU L, LI Y, et al. Development and validation of a scoring system to predict progression to acute-on-chronic liver failure in patients with acute exacerbation of chronic hepatitis B[J]. Hepatol Res, 2018, 48(9): 692-700. DOI: 10.1111/hepr.13062.
    [4]
    YUAN L, ZENG BM, LIU LL, et al. Risk factors for progression to acute-on-chronic liver failure during severe acute exacerbation of chronic hepatitis B virus infection[J]. World J Gastroenterol, 2019, 25(19): 2327-2337. DOI: 10.3748/wjg.v25.i19.2327.
    [5]
    TONG JJ, ZHAO W, MU XY, et al. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin Med J (Engl), 2019, 132(13): 1541-1549. DOI: 10.1097/CM9.0000000000000298.
    [6]
    CAO D, LI DJ, WANG Y, et al. Clinical significance of CTP combined with ABIC score in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin J Hepatol, 2019, 27(2): 118-122. DOI: 10.3760/cma.j.issn.1007-3418.2019.02.009.

    曹丹, 李大江, 王颖, 等. CTP联合ABIC评分预测乙型肝炎相关性慢加急性肝衰竭患者短期预后的临床意义[J]. 中华肝脏病杂志, 2019, 27(2): 118-122. DOI: 10.3760/cma.j.issn.1007-3418.2019.02.009.
    [7]
    ZHAO J, LI L, LI XH, et al. Value of a new predictive model in evaluating short-term prognosis of patients with hepatitis B virus related acute-on-chronic liver failure[J]. Chin Critical Care Med, 2020, 32(8): 988-993. DOI: 10.3760/cma.j.cn121430-20200102-00075.

    赵洁, 李力, 李秀惠, 等. 乙型肝炎病毒相关慢加急性肝衰竭患者短期预后模型的建立及预测价值研究[J]. 中华危重病急救医学, 2020, 32(8): 988-993. DOI: 10.3760/cma.j.cn121430-20200102-00075.
    [8]
    CHEN XB, ZHANG H, YANG JH. Predictive value of three scoring models for end-stage liver disease for short term prognosis in patients with acute-on-chronic hepatitis B liver failure[J]. Chin J Infect Dis, 2015, 33(8): 471-475. DOI: 10.3760/cma.j.issn.1000-6680.2015.08.006.

    陈学兵, 张浩, 杨家红. 三种终末期肝病评分模型对乙型肝炎慢加急性肝功能衰竭患者短期预后的预测价值[J]. 中华传染病杂志, 2015, 33(8): 471-475. DOI: 10.3760/cma.j.issn.1000-6680.2015.08.006.
    [9]
    LI ZY, YANG ST, WU LL, et al. Analysis of prognostic risk factors and establishment of prognosis model in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin J Infect Dis, 2019, 37(12): 737-741. DOI: 10.3760/cma.j.issn.1000-6680.2019.12.004.

    李子月, 杨士田, 吴玲玲, 等. 乙型肝炎病毒相关慢加急性肝衰竭患者预后危险因素分析及预后模型建立[J]. 中华传染病杂志, 2019, 37(12): 737-741. DOI: 10.3760/cma.j.issn.1000-6680.2019.12.004.
    [10]
    BAI Z, GUO X, TACKE F, et al. Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization[J]. Therap Adv Gastroenterol, 2019, 12: 1756284819881302. DOI: 10.1177/1756284819881302.
    [11]
    ZHANG T, DENG CL, LI Q, et al. Value of model for end-stage liver disease score combined with albumin detection in evaluating prognosis of patients with HBV-related acute-on-chronic liver failure[J]. Chin J Mod Med, 2019, 29(6): 96-99. DOI: 10.3969/j.issn.1005-8982.2019.06.022.

    张庭, 邓存良, 李芹, 等. MELD评分体系联合ALB检测对HBV-ACLF患者预后评估的价值[J]. 中国现代医学杂志, 2019, 29(6): 96-99. DOI: 10.3969/j.issn.1005-8982.2019.06.022.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article Metrics

    Article views (521) PDF downloads(55) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return